Venclexta (venetoclax)

pCPA File Number: 21375
Negotiation Status:
Concluded with an LOI
Indication(s):
Venetoclax (VENCLEXTA) in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL) who are fludarabine ineligible
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
PC0212-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: